Sign up for our complimentary
weekly e-journal

Main Newsletter
Mastery Series
Therapy Series
 
Bookmark and Share | Print Article | Items for the Week Previous | All Articles This Week | Next
This article originally posted and appeared in  DietMedicationType 2 DiabetesPrediabetesIssue 700

High Magnesium Intake May Offset Risk of Developing Diabetes

Magnesium intake may be particularly beneficial in offsetting risk of developing diabetes among those at high risk....
Advertisement

In this study, Hurby et al examined 7-yr associations between magnesium intake and the incidence of prediabetes and/or insulin resistance, and progression from these states to type 2 diabetes. A total of 2,582 participants ages 26–81 years old at baseline were selected. Magnesium intake and risk of metabolic impairment, defined as impaired fasting glucose (≥5.6–<7.0 mmol/L), impaired glucose tolerance (2-hr postload glucose ≥7.8–<11.1 mmol/L), insulin resistance, or hyperinsulinemia (≥90th percentile of HOMA-IR or fasting insulin, respectively), was estimated among those with normal baseline status. The risk of incident diabetes was estimated among those with baseline metabolic impairment. In participants without incident diabetes, the authors examined magnesium intake in relation to 7-yr changes in fasting and postload glucose and insulin, insulin resistance, and insulin sensitivity.

After adjusting for age, sex, and energy intake, compared to those with the lowest magnesium intake, those with the highest intake had 37% lower risk of incident metabolic impairment. For those with baseline metabolic impairment, higher intake was associated with a 32% lower risk of incident diabetes. In the combined population, the risk in those with the highest intake was 53% compared to those with the lowest intake of magnesium. Adjusting for risk factors and dietary fiber attenuated associations in the baseline normal population, but did not substantially affect associations in the metabolically impaired.

Higher magnesium intake tended to associate with lower follow-up fasting glucose and IR, but not fasting insulin, postload values, or insulin sensitivity. As a result, the authors concluded that magnesium intake may be particularly beneficial in offsetting risk of developing diabetes among those at high risk.

Practice Pearls:
  • Magnesium intake may be particularly beneficial in offsetting risk of developing diabetes among those at high risk.
  • Those with the highest intake had 37% lower risk of incident metabolic impairment.

Diabetes Care, October 2013 

Advertisement


 

Bookmark and Share | Print | Category | Home

This article originally posted 25 October, 2013 and appeared in  DietMedicationType 2 DiabetesPrediabetesIssue 700

Past five issues: Diabetes Clinical Mastery Series Issue 242 | Issue 782 | Diabetes Clinical Mastery Series Issue 241 | issue 781 | Diabetes Clinical Mastery Series Issue 240 |

2015 Most Popular Articles:

Neuropathy Due to Vitamin B-12 Deficiency, Not Diabetes
Posted April 30, 2015
What Is the Medicare Diabetes Prevention Act?
Posted May 08, 2015
Is Diet or Exercise the Best Way to Reduce Diabetes Risk?
Posted May 15, 2015
Metformin Reported in Use with Only 3.7% of Those with Prediabetes
Posted April 30, 2015
SGLT-2 Inhibitors: Teach from the Start and Manage Expectations
Posted May 03, 2015
Summary of Standards of Care for Diabetes for Primary Care
Posted April 30, 2015
Statin Therapy Associated with 46% Higher Risk of Type 2 Diabetes
Posted April 23, 2015
Fish Oil May Help with Diabetic Neuropathy
Posted May 15, 2015
Treating Sleep Apnea with CPAP Nightly Can Lower Diabetes Risk
Posted May 08, 2015
GLP-1 Analog May Help with NAFLD and Nonalcoholic Steatohepatitis
Posted May 15, 2015


Browse by Feature Writer & Article Category.
A. Lee Dellon, MD | Aaron I. Vinik, MD, PhD, FCP, MACP | Beverly Price | Charles W Martin, DD | Derek Lowe, PhD | Dr. Brian Jakes, Jr. | Dr. Fred Pescatore | Dr. Tom Burke, Ph.D | Eric S. Freedland | Evan D. Rosen | Ginger Kanzer-Lewis | Greg Milliger | Kristina Sandstedt | Laura Plunkett | Leonard Lipson, M.A. | Louis H. Philipson | Maria Emanuel Ryan, DDS, PhD | Marilyn Porter, RD, CDE | Melissa Diane Smith | Michael R. Cohen, RPh, MS, ScD, FASHP | Paul Chous, M.A., OD | Philip A. Wood PhD | R. Keith Campbell, Professor, B.Pharm, MBA, CDE | Richard K. Bernstein, MD | Sheri R. Colberg PhD | Sherri Shafer | Stanley Schwartz, MD, FACP, FACE | Steve Pohlit | Steven V. Edelman, M.D. | Timothy S. Hollingshead |

Cast Your Vote
Do you believe that we could have a bionic pancreas by 2017?
CME/CE of the Week
Hope Warshaw, MMSc, RD, CDE

Category: Nutrition
Credits: 1.25
Search Articles On Diabetes In Control